Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Cork

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Cardiology|August 3, 2021
Mortality and guideline-directed medical therapy in real-world heart failure patients with reduced ejection fractionPeter A McCullough, Hirsch S Mehta, Colin M Barker, et al.
Journal of Comparative Effectiveness Research|November 11, 2020
Healthcare utilization in clinically significant tricuspid regurgitation patients with and without heart failureColin M Barker, David P Cork, Peter A McCullough, et al.
Journal of Comparative Effectiveness Research|July 6, 2021
Healthcare utilization and guideline-directed medical therapy in heart failure patients with reduced ejection fractionPeter A McCullough, Hirsch S Mehta, Colin M Barker, et al.
Journal of Medical Economics|May 21, 2019
The healthcare burden of disease progression in medicare patients with functional mitral regurgitationPeter A McCullough, Hirsch S Mehta, David P Cork, et al.
Journal of Comparative Effectiveness Research|December 11, 2025
Healthcare cost and utilization before and after the development of significant tricuspid regurgitation by age, sex and raceDavid P Cork, Frank Medina, Lisa Kemp, et al.
Journal of Comparative Effectiveness Research|December 11, 2025
Racial and ethnic differences in diagnosis, healthcare utilization and 1-year outcomes for patients with significant tricuspid regurgitationFrank Medina, David P Cork, Rebecca Horn, et al.
The American Journal of Cardiology|January 1, 2021
Comparison of Survival in Patients With Clinically Significant Tricuspid Regurgitation With and Without Heart Failure (From the Optum Integrated File)Colin M Barker, David P Cork, Peter A McCullough, et al.
The American Journal of Cardiology|September 1, 2019
The Economic Impact of Mitral Regurgitation on Patients With Medically Managed Heart FailurePeter A McCullough, Hirsch S Mehta, Colin M Barker, et al.
Journal of Medical Economics|January 19, 2020
The economic impact of clinically significant tricuspid regurgitation in a large, administrative claims databaseDavid P Cork, Peter A McCullough, Hirsch S Mehta, et al.
ESC Heart Failure|May 30, 2020
Impact of mitral regurgitation on cardiovascular hospitalization and death in newly diagnosed heart failure patientsDavid P Cork, Peter A McCullough, Hirsch S Mehta, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Cardiology|August 3, 2021
Mortality and guideline-directed medical therapy in real-world heart failure patients with reduced ejection fractionPeter A McCullough, Hirsch S Mehta, Colin M Barker, et al.
Journal of Comparative Effectiveness Research|November 11, 2020
Healthcare utilization in clinically significant tricuspid regurgitation patients with and without heart failureColin M Barker, David P Cork, Peter A McCullough, et al.
Journal of Comparative Effectiveness Research|July 6, 2021
Healthcare utilization and guideline-directed medical therapy in heart failure patients with reduced ejection fractionPeter A McCullough, Hirsch S Mehta, Colin M Barker, et al.
Journal of Medical Economics|May 21, 2019
The healthcare burden of disease progression in medicare patients with functional mitral regurgitationPeter A McCullough, Hirsch S Mehta, David P Cork, et al.
Journal of Comparative Effectiveness Research|December 11, 2025
Healthcare cost and utilization before and after the development of significant tricuspid regurgitation by age, sex and raceDavid P Cork, Frank Medina, Lisa Kemp, et al.
Journal of Comparative Effectiveness Research|December 11, 2025
Racial and ethnic differences in diagnosis, healthcare utilization and 1-year outcomes for patients with significant tricuspid regurgitationFrank Medina, David P Cork, Rebecca Horn, et al.
The American Journal of Cardiology|January 1, 2021
Comparison of Survival in Patients With Clinically Significant Tricuspid Regurgitation With and Without Heart Failure (From the Optum Integrated File)Colin M Barker, David P Cork, Peter A McCullough, et al.
The American Journal of Cardiology|September 1, 2019
The Economic Impact of Mitral Regurgitation on Patients With Medically Managed Heart FailurePeter A McCullough, Hirsch S Mehta, Colin M Barker, et al.
Journal of Medical Economics|January 19, 2020
The economic impact of clinically significant tricuspid regurgitation in a large, administrative claims databaseDavid P Cork, Peter A McCullough, Hirsch S Mehta, et al.
ESC Heart Failure|May 30, 2020
Impact of mitral regurgitation on cardiovascular hospitalization and death in newly diagnosed heart failure patientsDavid P Cork, Peter A McCullough, Hirsch S Mehta, et al.
Pageof 3